Cargando…
Pharmacogenomic considerations in the opioid management of pain
Physicians continue to struggle with the clinical management of pain, in part because of the large interindividual variability in the efficacy, occurrence of side effects and undesired severe adverse drug reactions from the prescribed analgesics. Pharmacogenomics, the study of how an individual'...
Autores principales: | Jannetto, Paul J, Bratanow, Nancy C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3092117/ https://www.ncbi.nlm.nih.gov/pubmed/20854646 http://dx.doi.org/10.1186/gm187 |
Ejemplares similares
-
Pharmacogenomic considerations in opioid analgesia
por: Vuilleumier, Pascal H, et al.
Publicado: (2012) -
Update on the pharmacogenomics of pain management
por: Kaye, Alan David, et al.
Publicado: (2019) -
Opioid Therapy Pharmacogenomics for Noncancer Pain: Efficacy, Adverse Events, and Costs
por: Xu, Yan, et al.
Publicado: (2013) -
Considerations in selecting rapid-onset opioids for the management of breakthrough pain
por: Smith, Howard S
Publicado: (2013) -
Pharmacogenomics and Opioid Analgesics: Clinical Implications
por: Yiannakopoulou, Eugenia
Publicado: (2015)